A detailed study was recently conducted that evaluated the incidence, characteristics, mortality rates, and prevention strategies associated with urinary tract infections (UTIs)—particularly those associated with catheters (CAUTIs)—in critical care units during the COVID-19 pandemic. Held between 2020 and 2024 at the ICU of Wrocław’s University Hospital in Poland, the study encompassed 2,751 patients. The focus was on understanding UTIs’ incidence and impact on patient mortality, healthcare costs, and antimicrobial resistance development, especially as it pertains to hospital-acquired infections (HAIs).
Results indicated that 243 out of the 2,751 patients (8.83%) developed CAUTIs after 48 hours of admission, while 63 out of the 2,751 patients (2.3%) already had UTIs upon admission. An alarming finding was the significant prevalence of CAUTIs amongst females (12.32% compared to 6.85% in males) and in internal medicine patients (14.07% compared to surgical patients at 6.45%). These results highlight the urgent need for more robust infection prevention strategies and monitoring protocols for these demographic categories.
Another critical statistic thrown up by this research was the mean CAUTI density during the pandemic, which stood at 8.03 and was significantly higher than the post-pandemic period average of 6.25. However, there was no significant difference in CAUTI incidence between the COVID-positive and COVID-negative patients.
The study also revealed an unsettling increase in the percentage of dangerous pathogens present in CAUTIs during the pandemic as compared to the post-pandemic period, underlining the ripple effects of the pandemic on HAIs.
Despite the lack of statistical significance between the incidence of CAUTIs amongst COVID-positive and COVID-negative patients, the study findings still ring alarm bells about the management of critical care units in the pandemic’s wake. The results underline the importance of constant surveillance of CAUTIs, implementation of preventive measures, and regular evaluations as critical components in enhancing clinical results, especially in ICU settings.
Furthermore, the high global prevalence of HAIs, specifically CAUTIs, across ICUs necessitates a deeper understanding of these infections’ evolving characteristics and intervention strategies. This need has been magnified due to the significant number of preventable CAUTIs and the potential compromising of HAI prevention norms due to the pandemic.
The study’s outcomes deliver crucial insights on altering rates of infection and help shape effective interventions to boost patient outcomes and strengthen infection control practices in ICU. Increased awareness can also lead to better resource allocation within similar healthcare settings. Constant surveillance and efficient adherence to CAUTI preventive measures, such as those recommended by the CDC, can significantly impact clinical outcomes.
Source: https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-025-10996-2